vs
Side-by-side financial comparison of FEDERAL AGRICULTURAL MORTGAGE CORP (AGM) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $107.5M, roughly 1.7× FEDERAL AGRICULTURAL MORTGAGE CORP). On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 6.1%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 7.1%).
The Federal Agricultural Mortgage Corporation, also known as Farmer Mac, is a stockholder-owned, federally chartered corporation established by the U.S. Congress in 1988 under the Agricultural Credit Act of 1987. It was created to establish a secondary market for agricultural real estate and housing mortgage loans, to increase liquidity and the availability of long-term, stable credit for farmers, ranchers, and rural communities.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
AGM vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $107.5M | $185.2M |
| Net Profit | — | $1.7M |
| Gross Margin | — | 85.7% |
| Operating Margin | 56.3% | 8.6% |
| Net Margin | — | 0.9% |
| Revenue YoY | 6.1% | 23.7% |
| Net Profit YoY | — | -88.5% |
| EPS (diluted) | $3.69 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $107.5M | $185.2M | ||
| Q3 25 | $104.0M | $169.1M | ||
| Q2 25 | $102.6M | $154.7M | ||
| Q1 25 | $94.3M | $125.2M | ||
| Q4 24 | $101.3M | $149.7M | ||
| Q3 24 | $90.3M | $141.5M | ||
| Q2 24 | $89.9M | $126.7M | ||
| Q1 24 | $93.7M | $110.4M |
| Q4 25 | — | $1.7M | ||
| Q3 25 | $55.0M | $17.3M | ||
| Q2 25 | $54.8M | $-24.4M | ||
| Q1 25 | $49.7M | $-21.7M | ||
| Q4 24 | $56.5M | $14.7M | ||
| Q3 24 | $49.8M | $-6.7M | ||
| Q2 24 | $47.1M | $-15.7M | ||
| Q1 24 | $53.7M | $-48.4M |
| Q4 25 | — | 85.7% | ||
| Q3 25 | — | 88.5% | ||
| Q2 25 | — | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | — | 90.1% | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | — | 91.1% | ||
| Q1 24 | — | 87.7% |
| Q4 25 | 56.3% | 8.6% | ||
| Q3 25 | 64.1% | 20.3% | ||
| Q2 25 | 63.8% | -6.1% | ||
| Q1 25 | 66.9% | -6.3% | ||
| Q4 24 | 67.5% | 10.7% | ||
| Q3 24 | 69.0% | 15.3% | ||
| Q2 24 | 65.9% | 11.8% | ||
| Q1 24 | 72.8% | -25.1% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | 52.9% | 10.2% | ||
| Q2 25 | 53.4% | -15.8% | ||
| Q1 25 | 52.6% | -17.3% | ||
| Q4 24 | 55.8% | 9.8% | ||
| Q3 24 | 55.2% | -4.8% | ||
| Q2 24 | 52.4% | -12.4% | ||
| Q1 24 | 57.4% | -43.9% |
| Q4 25 | $3.69 | $0.00 | ||
| Q3 25 | $4.44 | $0.06 | ||
| Q2 25 | $4.48 | $-0.08 | ||
| Q1 25 | $4.01 | $-0.07 | ||
| Q4 24 | $4.62 | $0.05 | ||
| Q3 24 | $3.86 | $-0.02 | ||
| Q2 24 | $3.68 | $-0.05 | ||
| Q1 24 | $4.28 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $293.5M |
| Total DebtLower is stronger | $30.8B | $392.7M |
| Stockholders' EquityBook value | $1.7B | $274.2M |
| Total Assets | $35.4B | $949.9M |
| Debt / EquityLower = less leverage | 17.93× | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $293.5M | ||
| Q3 25 | — | $263.8M | ||
| Q2 25 | — | $231.0M | ||
| Q1 25 | — | $250.6M | ||
| Q4 24 | — | $249.9M | ||
| Q3 24 | $842.1M | $249.8M | ||
| Q2 24 | $923.0M | $260.1M | ||
| Q1 24 | $745.1M | $239.6M |
| Q4 25 | $30.8B | $392.7M | ||
| Q3 25 | $29.2B | $392.0M | ||
| Q2 25 | $28.9B | $391.3M | ||
| Q1 25 | $28.0B | $390.7M | ||
| Q4 24 | $27.5B | $390.1M | ||
| Q3 24 | $27.2B | $389.5M | ||
| Q2 24 | $26.8B | $388.9M | ||
| Q1 24 | $26.8B | $388.4M |
| Q4 25 | $1.7B | $274.2M | ||
| Q3 25 | $1.7B | $230.4M | ||
| Q2 25 | $1.5B | $204.3M | ||
| Q1 25 | $1.5B | $193.6M | ||
| Q4 24 | $1.5B | $194.0M | ||
| Q3 24 | $1.5B | $178.8M | ||
| Q2 24 | $1.5B | $132.5M | ||
| Q1 24 | $1.5B | $130.7M |
| Q4 25 | $35.4B | $949.9M | ||
| Q3 25 | $33.4B | $868.8M | ||
| Q2 25 | $33.0B | $815.3M | ||
| Q1 25 | $31.8B | $789.8M | ||
| Q4 24 | $31.3B | $785.0M | ||
| Q3 24 | $30.6B | $786.6M | ||
| Q2 24 | $30.2B | $749.5M | ||
| Q1 24 | $29.8B | $721.8M |
| Q4 25 | 17.93× | 1.43× | ||
| Q3 25 | 17.31× | 1.70× | ||
| Q2 25 | 18.70× | 1.92× | ||
| Q1 25 | 18.39× | 2.02× | ||
| Q4 24 | 18.48× | 2.01× | ||
| Q3 24 | 18.60× | 2.18× | ||
| Q2 24 | 17.87× | 2.93× | ||
| Q1 24 | 18.11× | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $80.1M | $16.3M |
| Free Cash FlowOCF − Capex | — | $16.0M |
| FCF MarginFCF / Revenue | — | 8.6% |
| Capex IntensityCapex / Revenue | 0.0% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | — | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.1M | $16.3M | ||
| Q3 25 | $74.2M | $35.7M | ||
| Q2 25 | $-47.7M | $-26.5M | ||
| Q1 25 | $-49.8M | $7.8M | ||
| Q4 24 | $612.6M | $-3.9M | ||
| Q3 24 | $-44.4M | $-23.0M | ||
| Q2 24 | $56.1M | $22.7M | ||
| Q1 24 | $233.3M | $-29.7M |
| Q4 25 | — | $16.0M | ||
| Q3 25 | — | $35.3M | ||
| Q2 25 | — | $-28.9M | ||
| Q1 25 | — | $7.5M | ||
| Q4 24 | $607.4M | $-4.2M | ||
| Q3 24 | $-44.4M | $-23.3M | ||
| Q2 24 | $52.6M | $21.6M | ||
| Q1 24 | $231.7M | $-31.5M |
| Q4 25 | — | 8.6% | ||
| Q3 25 | — | 20.9% | ||
| Q2 25 | — | -18.7% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | 599.8% | -2.8% | ||
| Q3 24 | -49.2% | -16.5% | ||
| Q2 24 | 58.5% | 17.0% | ||
| Q1 24 | 247.3% | -28.5% |
| Q4 25 | 0.0% | 0.2% | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | 0.0% | 1.6% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | 5.2% | 0.2% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 4.0% | 0.9% | ||
| Q1 24 | 1.7% | 1.6% |
| Q4 25 | — | 9.62× | ||
| Q3 25 | 1.35× | 2.06× | ||
| Q2 25 | -0.87× | — | ||
| Q1 25 | -1.00× | — | ||
| Q4 24 | 10.84× | -0.27× | ||
| Q3 24 | -0.89× | — | ||
| Q2 24 | 1.19× | — | ||
| Q1 24 | 4.34× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGM
Segment breakdown not available.
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
